Cascade Prodrug, Inc. — Form D/A
Cascade Prodrug, Inc. of Portland, OR, a company, filed a Form D amendment with the SEC on 2013-04-03. The offering totals $1.5M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-04-03
- Form: D/A
- Accession: 0001541764-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $1.3M
- Remaining: $193K
- Minimum investment: $20K
- Investors: 15
- Date of first sale: 2012-06-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-182196
Issuer
- Name: Cascade Prodrug, Inc.
- CIK: 0001541764
- Entity type: Corporation
- Jurisdiction: OREGON
- Incorporated: 2009
- Address: c/o Ater Wynne LLP, Portland, OR, 97209
- Phone: (541) 343-6025
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Allan Cochrane | Promoter | Eugene, OR |
| August Sick | Promoter | Eugene, OR |
| Allan Cochrane | Director | Eugene, OR |
| Allan Cochrane | Executive Officer | Eugene, OR |
| August Sick | Director | Eugene, OR |
| August Sick | Executive Officer | Eugene, OR |
| Lynnor G Stevenson | Director | Eugene, OR |
| August G Sick | Director | Eugene, OR |
| August G Sick | Executive Officer | Eugene, OR |
| Allan G Cochrane | Director | Eugene, OR |
| Allan G Cochrane | Executive Officer | Eugene, OR |
| Christopher G Schelling | Director | Eugene, OR |
| Lynnor B Stevenson | Director | Portland, OR |
Other filings by this issuer (7)
More